炎症
CXCL13型
淋巴
CCL11型
生发中心
淋巴结
嗜酸性粒细胞
酵母多糖
免疫学
医学
趋化因子
病理
化学
嗜酸性粒细胞趋化因子
趋化因子受体
B细胞
抗体
体外
哮喘
生物化学
作者
Yukako Tani,Yosuke Isobe,Yuki Imoto,Eri Segi‐Nishida,Yukihiko Sugimoto,Hiroyuki Arai,Makoto Arita
摘要
Resolution of inflammation is critical to restoration of tissue function after an inflammatory response. We previously demonstrated that 12/15‐lipoxygenase (12/15‐LOX)‐expressing eosinophils contribute to this process in murine zymosan‐induced peritonitis. In this study, eosinophils promoted resolution by regulating expression of macrophage CXCL13. Microarray analysis revealed that eosinophils significantly increased (~ 3‐fold) the expression of macrophage CXCL13 by a 12/15‐LOX‐dependent mechanism. CXCL13 depletion caused a resolution defect, with the reduced appearance of phagocytes carrying engulfed zymosan in the draining lymph nodes. Inflamed lymph node hypertrophy, a critical feature of the resolution process, was reduced by ~60% in eosinophil‐deficient mice, and adoptive transfer of eosinophils or administration of CXCL13 corrected this defect. Administration of the 12/15‐LOX‐derived mediator lipoxin A 4 (LXA 4 ) increased the expression of CXCL13 and restored the defect of lymph node hypertrophy in eosinophil‐deficient mice. These results demonstrate that eosinophils control the resolution of inflammation and draining lymph node hypertrophy through proresolving lipid mediators and the CXCL13 pathway in mice.—Tani, Y., Isobe, Y., Imoto, Y., Segi‐Nishida, E., Sugimoto, Y., Arai, H., Arita, M. Eosinophils control the resolution of inflammation and draining lymph node hypertrophy through the proresolving mediators and CXCL13 pathway in mice. FASEB J. 28, 4036‐4043 (2014). www.fasebj.org
科研通智能强力驱动
Strongly Powered by AbleSci AI